Q4 FY2023 Earnings
Financial report interval: 2023.10.01 - 2023.12.31
Overview: Vaxxinity(VAXX) the EBIT is -11.65 M (+44.05%);the EPS is -0.0895 (+44.82%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B44.05%
----
----
EPS
-0.089544.82%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf